EXEL
ExelixisCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
EXEL vs peer average
57/100
EXEL vs. peer average (C vs. C)
Grade spread
A 1 · B 2 · C 1 · D 5 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Diversified biotech peer with significant oncology exposure and stronger scale; highlights how EXEL still trades more on a concentrated cabozantinib base plus zanzalintinib pipeline execution.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
EXEL
Exelixis
AMGN
Amgen
Grade
C
D
Momentum
94
91
Value
65
61
Sentiment
32
27
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs AMGN
EXEL / AMGN
Grade Position
In line
EXEL vs. peer average (C vs. C)
57/100
Momentum
94
EXELValue
65
EXELSentiment
32
EXELRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs EXEL
AMGN is the first peer returned for this comparison set.